Madeline Sheeley

Dr. Madeline Sheeley

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2021 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
MSMadeline Sheeley
Madeline Sheeley
CAChaylen Andolino
Chaylen Andolino
VKViolet Abigail Kiesel
Violet Abigail Kiesel
DTDorothy Teegarden
Dorothy Teegarden

23 May 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
VKViolet Abigail Kiesel
Violet Abigail Kiesel
MSMadeline Sheeley
Madeline Sheeley
SDShawn Donkin
Shawn Donkin
MWMichael Wendt
Michael Wendt
SHStephen David Hursting
Stephen David Hursting
DTDorothy Teegarden
Dorothy Teegarden
Several cancers, including breast cancers, show dependence on glutamine metabolism. The purpose of the present study was to determine the mechanistic basis and impact of differential glutamine metabolism in nonmetastatic and metastatic murine mammary cancer cells. Universally labeled 13C5-glutamine metabolic tracing, qRT-PCR, measures of reductive–oxidative balance, and exogenous ammonium chloride treatment were used to assess glutamine reprogramming. Results show that 4 mM media concentration of glutamine, compared with 2 mM, reduced viability only in metastatic cells, and that this decrease in viability was accompanied by increased incorporation of glutamine-derived carbon into the tricarboxylic acid (TCA) cycle. While increased glutamine metabolism in metastatic cells occurred in tandem with a decrease in the reduced/oxidized glutathione ratio, treatment with the antioxidant molecule N-acetylcysteine did not rescue cell viability. However, the viability of metastatic cells was more sensitive to ammonium chloride treatment compared with nonmetastatic cells, suggesting a role of metabolic reprogramming in averting nitrogen cytotoxicity in nonmetastatic cells. Overall, these results demonstrate the ability of nonmetastatic cancer cells to reprogram glutamine metabolism and that this ability may be lost in metastatic cells.

4 August 2022 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
MSMadeline Sheeley
Madeline Sheeley
VKViolet A. Kiesel
Violet A. Kiesel
CAChaylen Andolino
Chaylen Andolino
NLNadia A. Lanman
Nadia A. Lanman
SDShawn S. Donkin
Shawn S. Donkin
DTDorothy Teegarden
Dorothy Teegarden

29 June 2021 in Research Square
Verified
Preprint
Open access
PDF file
MSMadeline Sheeley
Madeline Sheeley
VKViolet A Keisel
Violet A Keisel
NANadia M. Atallah
Nadia M. Atallah
SDShawn S. Donkin
Shawn S. Donkin
SHStephen D. Hursting
Stephen D. Hursting
DTDorothy Teegarden
Dorothy Teegarden
Background: Throughout metastatic progression, cancer cells acquire anchorage independence, or the ability to survive detached from the extracellular matrix (ECM). While untransformed epithelial cells reduce energy metabolism when detached, cancer cells display metabolic flexibility to continue important metabolic processes. Glucose and glutamine are predominant nutrients utilized for energy as well as other purposes, and their metabolism is regulated by cancer cells.Methods: The purpose of the current studies was to determine the effects of detachment on glucose and glutamine metabolism in human breast epithelial MCF10A cells transfected with the Harvey-ras oncogene (MCF10A-ras), a model of early-stage cancer. Detachment was simulated with poly-HEMA coated plates, and intracellular metabolic flux was determined using stably labeled 13C5-glutamine and 13C6-glucose tracers.Results: Results show reduced glutamine flux in detached cells as determined by reduced accumulation of label in glutamate (21%), malate (30%), and aspartate (23%) from 13C5-glutamine. Detachment also reduced flux of 13C6-glucose to pyruvate and lactate pools by 51% and 29%, respectively. Similarly, detachment reduced total intracellular pool sizes of pyruvate (51%), lactate (49%), α-ketoglutarate (43%), fumarate (32%), malate (19%), alanine (35%), serine (35%), and glutamate (28%) compared to attached cells, but citrate and aspartate pool sizes were unchanged. Compared to attached cells, detachment increased pyruvate carboxylase (PC) mRNA abundance and protein expression by 131% and 190%, respectively. In detachment, PC activity, determined by 13C6-glucose derived M + 3 isotopomers, was shown to preferentially replenish malate and aspartate, but not citrate pools. In addition, doxycycline-inducible shRNA depletion of PC significantly decreased, while doxycycline-inducible PC overexpression significantly increased, detached cell viability. Further, a switch from glutamine to PC activity for anaplerosis was demonstrated, as supplementation with the cell permeable analog of the tricarboxylic acid cycle intermediate, α-ketoglutarate, a downstream metabolite of glutamine, decreased PC mRNA abundance in detached cells.Conclusion: Collectively, these results suggest that detached breast cancer cells increase PC activity in response to decreased glutamine-derived anaplerosis to promote cell survival.